|
KDELR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.09240000168276E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.045780E-04 |
| Normal-vs-Stage2 |
8.112300E-02 |
| Normal-vs-Stage3 |
1.735700E-03 |
| Normal-vs-Stage4 |
6.491700E-02 |
| Stage1-vs-Stage2 |
7.446000E-01 |
| Stage1-vs-Stage3 |
8.640500E-02 |
| Stage1-vs-Stage4 |
6.934000E-01 |
| Stage2-vs-Stage3 |
1.574630E-01 |
| Stage2-vs-Stage4 |
5.379000E-01 |
| Stage3-vs-Stage4 |
5.469000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.71910000013042E-07 |
| Normal-vs-AfricanAmerican |
2.276100E-03 |
| Normal-vs-Asian |
3.023400E-01 |
| Caucasian-vs-AfricanAmerican |
3.573200E-01 |
| Caucasian-vs-Asian |
9.937400E-01 |
| AfricanAmerican-vs-Asian |
7.260400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.73249999960257E-07 |
| Normal-vs-Female |
1.981960E-04 |
| Male-vs-Female |
6.208400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.266500E-02 |
| Normal-vs-Extreme_Weight |
2.249900E-04 |
| Normal-vs-Obese |
8.31370000000664E-05 |
| Normal-vs-Extreme_Obese |
7.382600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.411400E-01 |
| Normal_Weight-vs-Obese |
2.890200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.732400E-01 |
| Extreme_Weight-vs-Obese |
5.476200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.369600E-01 |
| Obese-vs-Extreme_Obese |
1.463050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.300200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.57690000343902E-08 |
| Normal-vs-Age(61-80Yrs) |
1.138210E-03 |
| Normal-vs-Age(81-100Yrs) |
1.063620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.920800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.942300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.065400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.805550E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.443600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.551600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.76239952923652E-10 |
| Normal-VS-Type2 PRCC |
7.310000E-02 |
| Normal-VS-KIRP CIMP |
3.593800E-02 |
| Normal-VS-Unclassified PRCC |
6.362000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.523980E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.935800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.681000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.450400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.856190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.790840E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.406000E-04 |
| Normal-vs-N1 |
1.432000E-02 |
| Normal-vs-N2 |
1.117360E-01 |
| N0-vs-N1 |
7.398000E-01 |
| N0-vs-N2 |
1.542790E-01 |
| N1-vs-N2 |
2.958200E-01 |
|
|
